MarketPulse

mpox vaccine

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Bavarian Nordic Raises 2026 Outlook on Smallpox Vaccine Contract Win

Bavarian Nordic posts Q1 revenue of DKK 1.06B, raises full-year guidance to DKK 5.5-5.7B following USD 97M U.S. smallpox vaccine production contract.
BVNRYshare buy-backQ1 2026 earnings
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Bavarian Nordic Raises 2026 Outlook After $97M U.S. Smallpox Vaccine Contract

Bavarian Nordic raised full-year guidance to DKK 5.5-5.7B revenue with ~28% EBITDA margin after securing $97M U.S. smallpox vaccine production contract.
BVNRYshare buyback programQ1 2026 earnings